Worth asking what specifically was measured. Pain scores move with mood and function does not. Not on pregabalin but the pattern is familiar.

You have two changes at once here. You cannot attribute anything until one of them moves.

Imprint databases are mostly US-centric. A confident hit for another market is still a guess.